世界の神経栄養性角膜炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neurotrophic Keratitis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4575
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、神経栄養性角膜炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（防腐剤フリー人工涙液、局所抗生物質、タールソラフィ、羊膜移植、包帯コンタクトレンズ、組換えヒト神経成長因子）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・神経栄養性角膜炎治療の市場動向
・企業の競争状況、市場シェア
・神経栄養性角膜炎治療の種類別市場規模と予測2016-2027（防腐剤フリー人工涙液、局所抗生物質、タールソラフィ、羊膜移植、包帯コンタクトレンズ、組換えヒト神経成長因子）
・神経栄養性角膜炎治療の用途別市場規模と予測2016-2027（病院、外来手術センター、その他）
・神経栄養性角膜炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・神経栄養性角膜炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・神経栄養性角膜炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・神経栄養性角膜炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・神経栄養性角膜炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Allergan, Plc.、Abbott Laboratories, Inc.、Bausch & Lomb Incorporated、Bayer AG、CooperVision、Dompe farmaceutici S.p.A.、Johnson & Johnson、Novartis AG、ReGenTree, LLC.、Walgreens）
・結論

Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease.

Market Analysis and Insights: Global Neurotrophic Keratitis Treatment Market
The global Neurotrophic Keratitis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurotrophic Keratitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurotrophic Keratitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurotrophic Keratitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurotrophic Keratitis Treatment market.

Global Neurotrophic Keratitis Treatment Scope and Market Size
Neurotrophic Keratitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurotrophic Keratitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Preservative Free Artificial Tears
Topical Antibiotics
Tarsorraphy
Amniotic Membrane Transplantation
Bandage Contact Lenses
Recombinant Human Nerve Growth Factor

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan, Plc.
Abbott Laboratories, Inc.
Bausch & Lomb Incorporated
Bayer AG
CooperVision
Dompe farmaceutici S.p.A.
Johnson & Johnson
Novartis AG
ReGenTree, LLC.
Walgreens

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurotrophic Keratitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Preservative Free Artificial Tears
1.2.3 Topical Antibiotics
1.2.4 Tarsorraphy
1.2.5 Amniotic Membrane Transplantation
1.2.6 Bandage Contact Lenses
1.2.7 Recombinant Human Nerve Growth Factor
1.3 Market by Application
1.3.1 Global Neurotrophic Keratitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neurotrophic Keratitis Treatment Market Perspective (2016-2027)
2.2 Neurotrophic Keratitis Treatment Growth Trends by Regions
2.2.1 Neurotrophic Keratitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurotrophic Keratitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Neurotrophic Keratitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Neurotrophic Keratitis Treatment Industry Dynamic
2.3.1 Neurotrophic Keratitis Treatment Market Trends
2.3.2 Neurotrophic Keratitis Treatment Market Drivers
2.3.3 Neurotrophic Keratitis Treatment Market Challenges
2.3.4 Neurotrophic Keratitis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neurotrophic Keratitis Treatment Players by Revenue
3.1.1 Global Top Neurotrophic Keratitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Neurotrophic Keratitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Neurotrophic Keratitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurotrophic Keratitis Treatment Revenue
3.4 Global Neurotrophic Keratitis Treatment Market Concentration Ratio
3.4.1 Global Neurotrophic Keratitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurotrophic Keratitis Treatment Revenue in 2020
3.5 Neurotrophic Keratitis Treatment Key Players Head office and Area Served
3.6 Key Players Neurotrophic Keratitis Treatment Product Solution and Service
3.7 Date of Enter into Neurotrophic Keratitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neurotrophic Keratitis Treatment Breakdown Data by Type
4.1 Global Neurotrophic Keratitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Neurotrophic Keratitis Treatment Forecasted Market Size by Type (2022-2027)

5 Neurotrophic Keratitis Treatment Breakdown Data by Application
5.1 Global Neurotrophic Keratitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Neurotrophic Keratitis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neurotrophic Keratitis Treatment Market Size (2016-2027)
6.2 North America Neurotrophic Keratitis Treatment Market Size by Type
6.2.1 North America Neurotrophic Keratitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Neurotrophic Keratitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Neurotrophic Keratitis Treatment Market Size by Type (2016-2027)
6.3 North America Neurotrophic Keratitis Treatment Market Size by Application
6.3.1 North America Neurotrophic Keratitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Neurotrophic Keratitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Neurotrophic Keratitis Treatment Market Size by Application (2016-2027)
6.4 North America Neurotrophic Keratitis Treatment Market Size by Country
6.4.1 North America Neurotrophic Keratitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Neurotrophic Keratitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neurotrophic Keratitis Treatment Market Size (2016-2027)
7.2 Europe Neurotrophic Keratitis Treatment Market Size by Type
7.2.1 Europe Neurotrophic Keratitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Neurotrophic Keratitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Neurotrophic Keratitis Treatment Market Size by Type (2016-2027)
7.3 Europe Neurotrophic Keratitis Treatment Market Size by Application
7.3.1 Europe Neurotrophic Keratitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Neurotrophic Keratitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Neurotrophic Keratitis Treatment Market Size by Application (2016-2027)
7.4 Europe Neurotrophic Keratitis Treatment Market Size by Country
7.4.1 Europe Neurotrophic Keratitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Neurotrophic Keratitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neurotrophic Keratitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type
8.2.1 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application
8.3.1 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Region
8.4.1 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neurotrophic Keratitis Treatment Market Size (2016-2027)
9.2 Latin America Neurotrophic Keratitis Treatment Market Size by Type
9.2.1 Latin America Neurotrophic Keratitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Neurotrophic Keratitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Neurotrophic Keratitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Neurotrophic Keratitis Treatment Market Size by Application
9.3.1 Latin America Neurotrophic Keratitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Neurotrophic Keratitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Neurotrophic Keratitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Neurotrophic Keratitis Treatment Market Size by Country
9.4.1 Latin America Neurotrophic Keratitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Neurotrophic Keratitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neurotrophic Keratitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type
10.2.1 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application
10.3.1 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Country
10.4.1 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan, Plc.
11.1.1 Allergan, Plc. Company Details
11.1.2 Allergan, Plc. Business Overview
11.1.3 Allergan, Plc. Neurotrophic Keratitis Treatment Introduction
11.1.4 Allergan, Plc. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.1.5 Allergan, Plc. Recent Development
11.2 Abbott Laboratories, Inc.
11.2.1 Abbott Laboratories, Inc. Company Details
11.2.2 Abbott Laboratories, Inc. Business Overview
11.2.3 Abbott Laboratories, Inc. Neurotrophic Keratitis Treatment Introduction
11.2.4 Abbott Laboratories, Inc. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.2.5 Abbott Laboratories, Inc. Recent Development
11.3 Bausch & Lomb Incorporated
11.3.1 Bausch & Lomb Incorporated Company Details
11.3.2 Bausch & Lomb Incorporated Business Overview
11.3.3 Bausch & Lomb Incorporated Neurotrophic Keratitis Treatment Introduction
11.3.4 Bausch & Lomb Incorporated Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.3.5 Bausch & Lomb Incorporated Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Neurotrophic Keratitis Treatment Introduction
11.4.4 Bayer AG Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.4.5 Bayer AG Recent Development
11.5 CooperVision
11.5.1 CooperVision Company Details
11.5.2 CooperVision Business Overview
11.5.3 CooperVision Neurotrophic Keratitis Treatment Introduction
11.5.4 CooperVision Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.5.5 CooperVision Recent Development
11.6 Dompe farmaceutici S.p.A.
11.6.1 Dompe farmaceutici S.p.A. Company Details
11.6.2 Dompe farmaceutici S.p.A. Business Overview
11.6.3 Dompe farmaceutici S.p.A. Neurotrophic Keratitis Treatment Introduction
11.6.4 Dompe farmaceutici S.p.A. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.6.5 Dompe farmaceutici S.p.A. Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Neurotrophic Keratitis Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Neurotrophic Keratitis Treatment Introduction
11.8.4 Novartis AG Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 ReGenTree, LLC.
11.9.1 ReGenTree, LLC. Company Details
11.9.2 ReGenTree, LLC. Business Overview
11.9.3 ReGenTree, LLC. Neurotrophic Keratitis Treatment Introduction
11.9.4 ReGenTree, LLC. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.9.5 ReGenTree, LLC. Recent Development
11.10 Walgreens
11.10.1 Walgreens Company Details
11.10.2 Walgreens Business Overview
11.10.3 Walgreens Neurotrophic Keratitis Treatment Introduction
11.10.4 Walgreens Revenue in Neurotrophic Keratitis Treatment Business (2016-2021)
11.10.5 Walgreens Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neurotrophic Keratitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Preservative Free Artificial Tears
Table 3. Key Players of Topical Antibiotics
Table 4. Key Players of Tarsorraphy
Table 5. Key Players of Amniotic Membrane Transplantation
Table 6. Key Players of Bandage Contact Lenses
Table 7. Key Players of Recombinant Human Nerve Growth Factor
Table 8. Global Neurotrophic Keratitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neurotrophic Keratitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Neurotrophic Keratitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Neurotrophic Keratitis Treatment Market Share by Regions (2016-2021)
Table 12. Global Neurotrophic Keratitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Neurotrophic Keratitis Treatment Market Share by Regions (2022-2027)
Table 14. Neurotrophic Keratitis Treatment Market Trends
Table 15. Neurotrophic Keratitis Treatment Market Drivers
Table 16. Neurotrophic Keratitis Treatment Market Challenges
Table 17. Neurotrophic Keratitis Treatment Market Restraints
Table 18. Global Neurotrophic Keratitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Neurotrophic Keratitis Treatment Market Share by Players (2016-2021)
Table 20. Global Top Neurotrophic Keratitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophic Keratitis Treatment as of 2020)
Table 21. Ranking of Global Top Neurotrophic Keratitis Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Neurotrophic Keratitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neurotrophic Keratitis Treatment Product Solution and Service
Table 25. Date of Enter into Neurotrophic Keratitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Neurotrophic Keratitis Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Neurotrophic Keratitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Neurotrophic Keratitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Neurotrophic Keratitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Neurotrophic Keratitis Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Neurotrophic Keratitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Neurotrophic Keratitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Neurotrophic Keratitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Neurotrophic Keratitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Neurotrophic Keratitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Neurotrophic Keratitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Neurotrophic Keratitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Neurotrophic Keratitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Neurotrophic Keratitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Neurotrophic Keratitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Neurotrophic Keratitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Neurotrophic Keratitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Neurotrophic Keratitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Neurotrophic Keratitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Neurotrophic Keratitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Neurotrophic Keratitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Neurotrophic Keratitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Neurotrophic Keratitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Neurotrophic Keratitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Allergan, Plc. Company Details
Table 66. Allergan, Plc. Business Overview
Table 67. Allergan, Plc. Neurotrophic Keratitis Treatment Product
Table 68. Allergan, Plc. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 69. Allergan, Plc. Recent Development
Table 70. Abbott Laboratories, Inc. Company Details
Table 71. Abbott Laboratories, Inc. Business Overview
Table 72. Abbott Laboratories, Inc. Neurotrophic Keratitis Treatment Product
Table 73. Abbott Laboratories, Inc. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 74. Abbott Laboratories, Inc. Recent Development
Table 75. Bausch & Lomb Incorporated Company Details
Table 76. Bausch & Lomb Incorporated Business Overview
Table 77. Bausch & Lomb Incorporated Neurotrophic Keratitis Treatment Product
Table 78. Bausch & Lomb Incorporated Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 79. Bausch & Lomb Incorporated Recent Development
Table 80. Bayer AG Company Details
Table 81. Bayer AG Business Overview
Table 82. Bayer AG Neurotrophic Keratitis Treatment Product
Table 83. Bayer AG Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 84. Bayer AG Recent Development
Table 85. CooperVision Company Details
Table 86. CooperVision Business Overview
Table 87. CooperVision Neurotrophic Keratitis Treatment Product
Table 88. CooperVision Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 89. CooperVision Recent Development
Table 90. Dompe farmaceutici S.p.A. Company Details
Table 91. Dompe farmaceutici S.p.A. Business Overview
Table 92. Dompe farmaceutici S.p.A. Neurotrophic Keratitis Treatment Product
Table 93. Dompe farmaceutici S.p.A. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 94. Dompe farmaceutici S.p.A. Recent Development
Table 95. Johnson & Johnson Company Details
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson Neurotrophic Keratitis Treatment Product
Table 98. Johnson & Johnson Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis AG Company Details
Table 101. Novartis AG Business Overview
Table 102. Novartis AG Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 103. Novartis AG Recent Development
Table 104. ReGenTree, LLC. Company Details
Table 105. ReGenTree, LLC. Business Overview
Table 106. ReGenTree, LLC. Neurotrophic Keratitis Treatment Product
Table 107. ReGenTree, LLC. Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 108. ReGenTree, LLC. Recent Development
Table 109. Walgreens Company Details
Table 110. Walgreens Business Overview
Table 111. Walgreens Neurotrophic Keratitis Treatment Product
Table 112. Walgreens Revenue in Neurotrophic Keratitis Treatment Business (2016-2021) & (US$ Million)
Table 113. Walgreens Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurotrophic Keratitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Preservative Free Artificial Tears Features
Figure 3. Topical Antibiotics Features
Figure 4. Tarsorraphy Features
Figure 5. Amniotic Membrane Transplantation Features
Figure 6. Bandage Contact Lenses Features
Figure 7. Recombinant Human Nerve Growth Factor Features
Figure 8. Global Neurotrophic Keratitis Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Neurotrophic Keratitis Treatment Report Years Considered
Figure 13. Global Neurotrophic Keratitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Neurotrophic Keratitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Neurotrophic Keratitis Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Neurotrophic Keratitis Treatment Market Share by Regions (2022-2027)
Figure 17. Global Neurotrophic Keratitis Treatment Market Share by Players in 2020
Figure 18. Global Top Neurotrophic Keratitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophic Keratitis Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Neurotrophic Keratitis Treatment Revenue in 2020
Figure 20. Global Neurotrophic Keratitis Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Neurotrophic Keratitis Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Neurotrophic Keratitis Treatment Market Share by Type (2016-2027)
Figure 24. North America Neurotrophic Keratitis Treatment Market Share by Application (2016-2027)
Figure 25. North America Neurotrophic Keratitis Treatment Market Share by Country (2016-2027)
Figure 26. United States Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Neurotrophic Keratitis Treatment Market Share by Type (2016-2027)
Figure 30. Europe Neurotrophic Keratitis Treatment Market Share by Application (2016-2027)
Figure 31. Europe Neurotrophic Keratitis Treatment Market Share by Country (2016-2027)
Figure 32. Germany Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Neurotrophic Keratitis Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Neurotrophic Keratitis Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Neurotrophic Keratitis Treatment Market Share by Region (2016-2027)
Figure 42. China Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Neurotrophic Keratitis Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Neurotrophic Keratitis Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Neurotrophic Keratitis Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Neurotrophic Keratitis Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Neurotrophic Keratitis Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Neurotrophic Keratitis Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Neurotrophic Keratitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan, Plc. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 62. Abbott Laboratories, Inc. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 63. Bausch & Lomb Incorporated Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 65. CooperVision Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 66. Dompe farmaceutici S.p.A. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 68. Novartis AG Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 69. ReGenTree, LLC. Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 70. Walgreens Revenue Growth Rate in Neurotrophic Keratitis Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の神経栄養性角膜炎市場規模・現状・予測（2021年-2027年）

Global Neurotrophic Keratitis Market Size, Status and Forecast 2021-2027
QFJ1-5884 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、神経栄養性角膜炎の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、外科的介入）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の神経栄養性角膜炎治療薬市場規模・現状・予測（2021年-2027年）

Global Neurotrophic Keratitis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5885 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、神経栄養性角膜炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、外科的介入）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年）

Global Glial Cell Line Derived Neurotrophic Factor Market Size, Status and Forecast 2021-2027
QFJ1-5755 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、グリア細胞株由来神経栄養因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GSK-812、LAUR-301、TW-002、AMT-090、その他）、用途別市場規模（筋萎縮性側索硬化症、脳虚血、パーキ...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の神経栄養性角膜炎市場規模・現状・予測（2021年-2027年） Neurotrophic keratitis (NK) is a degenerative disease of the cornea caused by damage of the trigeminal nerve, which results in impairment of corneal sensitivity, spontaneous corneal epithelium breakdown, poor corneal healing and development of corneal ulceration, melting and perforation. Market Anal…
世界の神経栄養性角膜炎治療薬市場規模・現状・予測（2021年-2027年） Neurotrophic keratitis (NK) is a degenerative disease of the cornea caused by damage of the trigeminal nerve, which results in impairment of corneal sensitivity, spontaneous corneal epithelium breakdown, poor corneal healing and development of corneal ulceration, melting and perforation. Market Anal…
世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
グリア細胞株由来神経栄養因子のグローバル市場調査 2019年 The global Glial Cell Line Derived Neurotrophic Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glial Cell Line Derived Neurotrophic Factor volume and value at global level, regional level an…
世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年） Intra-amniotic infection is a common occurrence in pregnant women, which affects both the mother and baby. Intra-amniotic infection is also known as chorioamnionitis. The incidence is high at lower gestational ages. Market Analysis and Insights: Global Intra-amniotic Infection Treatment Market The …